CTC Welcomes New Member Camargo

CTC is proud to welcome as a new member Camargo Pharmaceutical Services. Camargo joins at an important time for members engaged in BioCalifornia, our life sciences program. As BioCalifornia expands into new services for emerging companies, Camargo will be among the members supporting product development and regulatory strategy and planning for BioCalifornia stakeholders.

About Camargo


Camargo Pharmaceutical Services is the most experienced global strategist providing comprehensive drug development services specialized for the 505(b)(2) approval pathway and analogous European processes. By assessing the scientific, medical, regulatory and commercial viability of product development opportunities, Camargo systematically builds and executes complete development plans that align with business strategies and that ensure FDA buy-in every step of the way. 

Camargo has guided more than 200 FDA approvals and works with product developers across more than 25 countries.

To learn more about Camargo, please visit the company's website here.

Learn more about how you can get involved starting with membership here.